ELISA Analyzers Market Report
ELISA Analyzers Market by Type (Optical Filter ELISA Analyzer and Optical Grating ELISA Analyzers), Mode (Automated ELISA Analyzers and Semi-Automated ELISA Analyzers), Application (Immunology, Vaccine Development, Drug Monitoring, and Others), End-user (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organization, and Diagnostic Laboratories), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032
ELISA Analyzers Overview
The ELISA testing procedure is automated and optimised using sophisticated laboratory equipment called ELISA (Enzyme-Linked Immunosorbent Assay) Analyzers. Immunology and clinical laboratories frequently employ the ELISA technique to identify and measure the quantity of antibodies, antigens, proteins, and hormones in a sample. The test process is streamlined by ELISA Analyzers, which deliver precise and effective results for diagnostic and research purposes. ELISA Analyzers automate the numerous ELISA process steps, minimising manual handling and the possibility of mistakes. Throughput and efficiency can be increased by handling numerous samples at once.
Global ELISA Analyzers Market Analysis
The global ELISA analyzers market size was $576.3 million in 2022 and is predicted to grow with a CAGR of 3.9%, by generating a revenue of $843.9 million by 2032.
COVID-19 Impact on Global ELISA Analyzers Market
The COVID-19 pandemic had a profound impact on the ELISA analyzers market. ELISA Antibody tests, which were in high demand during the pandemic, are made possible by analyzers. These tests were conducted to look for previous illnesses, track seroprevalence, and gauge population immunity levels. ELISA analyzers were used in the development and evaluation of COVID-19 treatments and vaccines. They helped researchers measure immune responses and assess the efficacy of possible therapies and immunisations.
The pandemic brought to light the value of strong diagnostic tools. In the years following the pandemic, it is anticipated that the in vitro diagnostic sector, which includes ELISA analyzers, will hold up well and continue to expand steadily.
Increasing Prevalence of Chronic Diseases to Drive the Market Growth
The demand for diagnostic tests like ELISA is driven by the increase in the prevalence of chronic diseases like cancer, autoimmune diseases, cardiovascular problems, and infectious diseases. The reliable detection and quantification of disease-related biomarkers by ELISA analyzers is essential for the early diagnosis and monitoring of various disorders. The performance of ELISA analyzers is improved by ongoing breakthroughs in immunoassay technologies, including increase in sensitivity, specificity, and multiplexing capabilities. These developments increase the need for more advanced and dependable devices. The development of targeted medicines and personalised medicine has increased the demand for diagnostic procedures that can recognise biomarkers. To find biomarkers that assist in customising therapy for particular patients, ELISA analyzers are utilised in research and clinical settings.
High Initial Cost to Restrain Market Growth
The cost of purchasing an ELISA analyzer might be high, particularly for smaller healthcare organisations and laboratories with tight budgets. Some potential purchasers may be turned off by the large initial expenditure, especially in environments with limited resources. Some ELISA analyzers could have a challenging learning curve and need specialised training for safe use and upkeep. For smaller labs with less technical competence, the complexity of the instruments can be a barrier. In some applications, ELISA analyzers may face competition from other diagnostic technologies including molecular diagnostics and quick point-of-care assays. Healthcare facilities may favour different technologies over ELISA depending on their testing requirements and preferences.
Expansion of Immunoassay Applications of Cancer to Drive Excellent Opportunities
Point-of-care testing (POCT) is a trend that is probably going to continue, and ELISA analyzers could be very useful in this field. Because of advancements in miniaturisation and portability, compact and user-friendly ELISA analyzers are perfect for resource-constrained places and decentralised healthcare settings. ELISA analyzers can be customised for a range of immunoassay applications in addition to traditional ELISAs. The versatility of ELISA platforms allows for the development of multiplex assays, which detect numerous analytes simultaneously in a single sample.
Global ELISA Analyzers Market Share, by Type, 2022
The optical filter ELISA analyzer sub-segment accounted for the highest share in 2022. Specific light wavelengths can be selectively transmitted or blocked using optical filters. These filters are employed in ELISA analyzers to precisely detect the signals produced during the ELISA experiment, improving measurement sensitivity and specificity. This yields precise and trustworthy data, which are essential for diagnostic and research applications.
Global ELISA Analyzers Market Share, by Mode, 2022
The automated ELISA analyzers sub-segment accounted for the highest market size in 2022. The ELISA testing procedure is streamlined by automation, which lowers manual labour and mistakes made by people. Without requiring constant user input, automated ELISA analyzers may handle many samples at once and carry out tasks such as sample dispensing, incubation, cleaning, and detection. This vastly increases the effectiveness of laboratory processes, enabling quicker turnaround times for test findings.
Global ELISA Analyzers Market Share, by Application, 2022
The vaccine development sub-segment accounted for the highest market size in 2022. ELISA analyzers are employed in the early phases of vaccine development to characterise antigens. They provide crucial information for choosing the best antigens for vaccination candidates by assisting in the identification and quantification of certain antigens or epitopes that elicit an immune response.
Global ELISA Analyzers Market Share, by End-user, 2022
The diagnostic laboratories sub-segment accounted for the highest market size in 2022. Diagnostic laboratories usually handle a large number of samples on a daily basis. Automated ELISA analyzers increase workflow efficiency by automating the testing method and reducing manual intervention. Because of this automation, laboratories can process more samples in a shorter amount of time, increasing productivity and speeding up the delivery of test findings.
Global ELISA Analyzers Market Share, by Region, 2022
The North America ELISA analyzers market accounted for the highest market share in 2022. When it comes to medical technology breakthroughs, including diagnostic tools like ELISA analyzers, North America is in the forefront. Continuous advancements in automation, multiplexing, and data analysis have produced advanced ELISA analyzer platforms that are more accurate and productive. Chronic illnesses like cancer, diabetes, cardiovascular issues, and autoimmune diseases are very common in the area. The prevalence of ELISA analyzers in the healthcare industry is a result of their extensive usage in the diagnosis and monitoring of various illnesses.
Competitive Scenario in the Global ELISA Analyzers Market
Product development and geographic expansion are major players functioning in the highly competitive global ELISA analyzers market. Some of the leading ELISA analyzers market players are Thermo Fisher Scientific, QIAGEN, Abcam, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer Inc., Merck KGaA, BioTech, F. Hoffmann-La Roche Ltd., and Danaher Corporation.
Historical Market Estimations
Base Year for Market Estimation
Forecast Timeline for Market Projection
North America, Europe, Asia-Pacific, and LAMEA
Segmentation by Type
Segmentation by Mode
Segmentation by Application
Segmentation by End-user
Key Companies Profiled
Q1. What is the size of the ELISA analyzers market?
A. The size of the ELISA analyzers market was over $576.3 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.9% during the forecast period.
Q2. Which are the major companies in the ELISA analyzers market?
A. Thermo Fisher Scientific and F. Hoffmann-La Roche Ltd. are some of the key players in the global ELISA Analyzers market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. The Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What are the strategies opted by the leading players in this market?
A. Product development and geographic expansion are the two key strategies opted by the operating companies in this market.
Q5. Which companies are investing more on R&D practices?
A. Thermo Fisher Scientific and F. Hoffmann-La Roche Ltd. are the companies investing more on R&D activities for developing new products and technologies.